Active Recombinant Human IL32

• Cat.No.: IL32-640H
• Product Overview: Recombinant Human IL32 (Accession # NP_001012649) was produced in E. coli-derived.

Specification

• Source: E. coli
• Species: Human
• Predicted N Terminal: Met
• Form: Supplied as a 0.2 µm filtered solution in HEPES, NaCl, DTT and CHAPS.
• Bio-activity: Measured by its ability to induce TNF-alpha secretion by RAW 264.7 mouse monocyte/macrophage cells under serum free conditions in the presence of 10 µg/mL of Polymyxin B. Kim, S.H. et al. (2005) Immunity 22:131.The ED50 for this effect is typically 10-50 ng/mL.
• Molecular Mass: Recombinant Human IL32 has a calculated MW of 23.1 kDa. In SDS-PAGE migrates as 28 kDa & some aggregates, reducing conditions.
• Purity: >90%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• Storage: Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).
• Tag: Non

Gene Information

• Gene Name: IL32 interleukin 32 [ Homo sapiens ]
• Official Symbol: IL32
• Synonyms: IL32; interleukin 32; interleukin-32; natural killer cell transcript 4; NK4; TAIF; TAIFb; TAIFd; interleukin-32 eta; interleukin-32 small; interleukin-32 theta; natural killer cells protein 4; tumor necrosis factor alpha-inducing factor; TAIFa; TAIFc; IL-32beta; IL-32alpha; IL-32delta; IL-32gamma
• Gene ID: 9235
• mRNA Refseq: NM_001012631
• Protein Refseq: NP_001012649
• MIM: 606001
• UniProt ID: P24001
• Chromosome Location: 16p13.3